Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters


Junior Editorial Board

  • W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.
    Research Interests: cancer immunotherapy; T-cell biology; drug discovery; LAG3; MHC
  • Department of Hepato-Pancreato-Biliary Surgery, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
    Research Interests: chemoresistance; pancreatic cancer; tumor microenvironment; pharmacokinetics; metabolism; cell biology
  • Edison Biotechnology Institute, Ohio University, Athens, OH, USA.
    Research Interests: growth hormone; cancer; receptors; drug efflux; EMT; combination therapy; immune-evasion; immune-therapy
  • Organic Chemistry Laboratory, University of Bayreuth, Bayreuth, Germany.
    Research Interests: medicinal chemistry; drug design; epigenetics; metal-based drugs; alkylating agents; tubulin-binding drugs; kinase inhibitors; HDAC inhibitors
  • Department of Pathology, University of California, San Diego, CA, USA.
    Research Interests: extracellular vesicles; non-coding RNAs; metabolism; signaling transduction; breast cancer
  • Hormel Institute, University of Minnesota, Austin, MN, USA.
    Research Interests: ovarian cancer; cell death; necroptosis; cancer stem cells; chemoresistance; metabolism; DNA damage and repair; ovary and brain
  • Department of Biological Sciences, University of South Carolina, Columbia, SC, USA.
    Research Interests: breast cancer biology; caner stem cells; microRNA; HER2-targeted therapy; immune escape mechanism; immunotherapy
  • Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
    Research Interests: cancer therapeutics; tumor microenvironment; cancer-associated fibroblasts; drug pharmacology; drug resistance
  • Laboratory of Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, Rome, Italy.
    Research Interests: mesothelioma; metformin; CSC; translational oncology; chemoresistance; TKI; Ephrin; EMT
  • Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
    Research Interests: anti-cancer drug repurposing; hypoxia; small molecules;  three-dimensional cell cultures
  • Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.
    Research Interests: non-small cell lung cancer; p53 pathway; oxidative stress; PARP-1 inhibition; pancreatic cancer; targeted therapies
  • Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
    Research Interests: exosomes; extracellular vesicles; 3D culture systems; tumoroids; protein moonlighting; cancer; omics; gene regulation
  • Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
    Research Interests: organoids; anticancer drugs; drug resistance; CSCs; bladder cancer; colorectal cancer
  • Department of Basic Sciences, Preparatory Year Deanship, King Faisal University, Al-Ahsa, Saudi Arabia.
    Research Interests: cancer therapy; tumor microenvironment; nutraceuticals; polyphenols
  • Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
    Research Interests: autophagy; tumor microenvironment; cell metabolism; dormancy; nutraceutics; epigenetics; 3D models; personalized cancer therapy
  • Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
    Research Interests: polymeric micelles; gene therapy; micelleplexes; controlled release
  • Department of Physiology and Cell Biology, University of South Alabama College of Medicine, Mobile, AL, USA.
    Research Interests: triple negative breast cancer; DNA damage; DNA repair; base excision repair
  • Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
    Research Interests: cancer immunotherapy; targeted therapy; cancer metastasis; tumor microenvironment; animal models; pancreatic cancer; breast cancer metastasis
  • Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida, India.
    Research Interests: bio/nanomaterial; cancer drug delivery; phytonanomedicine and tissuee engineering
  • Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
    Research Interests: circulating tumor cells (CTCs); liquid biopsy; cancer metastasis; non-invasive biomarkers
  • Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
    Research Interests: cancer drug resistance; cancer biology; genomics; precision oncology
  • Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.
    Research Interests: drug discovery from natural product; cancer treatment; molecular mechanisms of anticancer agents; anticancer drug resistance
  • Department of Animal Nutrition, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Jabłonna, Poland.
    Research Interests: DNA repair; p53 gene; human cancers like liver and pancreas; oxidative stress in gastrointestinal tract; BER and NER pathway
  • Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia.
    Research Interests: spatial transcriptomics; lung cancer; head and neck cancer; liquid biopsy; COVID-19; biomarkers; immuno-oncology
  • Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
    Research Interests: exosomes; miRNAs; prostate cancer; extracellular vesicles; stem cell
  • Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH, USA.
    Research Interests: growth factor signaling; steroid receptor/coactivator signaling; the interplay between these two signaling pathways in cancer progression and metastasis
  • Department of Woman’s and Child’s Health, University of Padova, Padova, Italy.
    Research Interests: high throughput drug screening (HTS); medulloblastoma; acute lymphoblastic leukemia; pediatric cancer; cell cycle; apoptosis; kinase inhibitors
  • Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milan, Italy.
    Research Interests: cancer; theragnostics; targeted therapy; nanotechnology; nanomedicine; multifunctional nanomaterials; nanocarriers; drug delivery
  • Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
    Research Interests: cancer metabolism; cancer therapy; chemo-resistant tumor models; drug resistance metabolism; cell death; reactive oxygen species; cancer cell signaling; mitochondrial-triggered cell death
  • Adelaide Medical School and Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, Australia.
    Research Interests: cancer biology; prostate cancer; lipid metabolism; angiogenesis and lymphangiogenesis; drug discovery
  • Department of Biology, University of Rome Tor Vergata, Rome, Italy.
    Research Interests: topoisomerase; cancer; drug development; DNA nanocage; drug delivery; CAR-T; immunotherapy
  • Department of Obstetrics and Gynecology, University of Texas Health San Antonio, San Antonio, TX, USA.
    Research Interests: gynecological cancer; drug discovery; neuroimmunology; neuroendocrinology; glioma; targeted therapy; immunology
  • Edison Biotechnology Institute, Konneker Research Labs, Ohio University, Athens, OH, USA.
    Research Interests: cancer metabolism; the warburg effect; energy homeostasis; growth hormone; drug resistance
  • Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
    Research Interests: preclinical drug testing; cell death assays; cell signaling pathways; drug resistance mechanisms
  • School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
    Research Interests: cancer; targeted drug delivery; tumor microenvironment; cancer nanomedicine; biomimetic nanotechnology; biomaterials; drug resistance
  • Department of Health Sciences, University of Florence, Florence, Italy.
    Research Interests: immunotherapy; prostate cancer; gastric cancer; renal cell carcinoma; chemotherapy
  • Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
    Research Interests: genome stability; DNA replication; DNA repair; nucleotide metabolism; cancer therapy; precision medicine; drug resistance; drug combinations
  • Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B·ARGO), Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
    Research Interests: metastatic prostate cancer; bladder cancer; therapy resistance; chemotherapy; target therapies; predictive biomarkers
  • Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL, USA
    Research Interests: cancer biology; signaling pathways; biomarkers; apoptosis; PI3K/mTOR signaling; head and neck cancer; targeted therapy; ovarian cancer; stem cells
  • Department of Molecular Pathology, Hiroshima University, Hiroshima, Japan.
    Research Interests: prostate cancer; renal cell carcinoma; bladder cancer; immunohistochemistry; drug resistance; molecular biology
  • Department of Cell Biology, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
    Research Interests: cancer drug resistance; anticancer drugs; cancer biomarker; cancer cell biology; protein-protein interaction; protein modification
  • Wuhan Senstar Biotech, Wuhan, China; Translational Medicine Engineering Research Center of Guangdong Province, Foshan, China.
    Research Interests: nanotechnology; smart nanoparticles; targeted drug delivery; combination cancer therapy
  • Neonate and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
    Research Interests: lung cancer; epigenetics; small molecule therapeutics; immunooncology; radiation biology
  • Department of Biochemistry and Molecular Biology, College of Natural Sciences, Colorado State University, Fort Collins, CO, USA.
    Research Interests: cell migration; actin cytoskeleton; ADF/cofilin; breast cancer; triple negative breast cancer; androgen receptor; targeted therapy
  • Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    Research Interests: cancer; sarcoma; plasticity; single-cell; bioinformatics; tumor microenvironment
  • Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
    Research Interests: tumor microenvironment; cancer immunotherapy; breast and lung Cancer; tumor metastasis; non-coding RNAs; cancer stem cells and radioresistance
  • Department of Health Science, Laboratory of Molecular Pathology, Università del Piemonte Orientale, Novara, Italy.
    Research Interests: cancer metabolism; autophagy; cancer biology; tumor microenvironment; genetic manipulation
  • Department of Medical Biology, Centre Scientifique de Monaco (CSM), Monaco, Monaco.
    Research Interests: ferroptosis; amino acid transporters; cancer; redox regulation; oxidative stress; metabolism
  • Department of Biological and Biomedical Sciences, Glasgow Caledonian University, Scotland, UK.
    Research Interests: acute lymphoblastic leukaemia; multiple myeloma; acute myeloid leukaemia; chemotherapy resistance
  • Cancer Drug Resistance Group, i3S - Instituto de Investigação e Inovação em Saúde, IPATIMUP - Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
    Research Interests: drug discovery; pancreatic cancer; lung cancer; cancer drug resistance; cancer therapy; cancer biology; extracellular vesicles
  • Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
    Research Interests: colon cancer therapeutics; biomimetic nano delivery systems; targeted drug delivery; digestive disease
  • Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Research Interests: tumor metastasis; mouse models; tumor immunology; drug discovery; drug resistance; targeted therapy
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
    Research Interests: prostate cancer; cancer metabolism; metabolic imaging; metabolomics; diet&lipid metabolism; cancer microenvironment; resistance to endocrine therapies; cancer progression
  • Department of Radiology, Shengjing Hospital of China Medical University, Liaoning, China.
    Research Interests: natural products; cancer resistance; cancer biology; apoptosis; immunotherapy; exosomes; epigenetics
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties